Trinity Biotech plc (TRIB)

Trinity Biotech Revenue

Trinity Biotech had revenue of $56.71M in the twelve months ending March 31, 2024, down -8.06% year-over-year. Revenue in the quarter ending March 31, 2024 was $14.70M, a -0.84% decrease year-over-year. In the year 2023, Trinity Biotech had annual revenue of $56.83M, a decrease of -9.10%.

• Revenue (ttm): $56.71M
• Revenue Growth: -8.06%
• P/S Ratio: 0.27
• Revenue / Employee: $149,229
• Employees: 380
• Market Cap: 15.51M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	56.83M	-5.69M	-9.10%
Dec 31, 2022	62.52M	-18.63M	-22.96%
Dec 31, 2021	81.15M	-20.83M	-20.43%
Dec 31, 2020	101.98M	11.55M	12.77%
Dec 31, 2019	90.44M	-6.60M	-6.80%
Dec 31, 2018	97.04M	-2.11M	-2.12%
Dec 31, 2017	99.14M	-471.00K	-0.47%
Dec 31, 2016	99.61M	-584.00K	-0.58%
Dec 31, 2015	100.20M	-4.68M	-4.46%
Dec 31, 2014	104.87M	13.66M	14.97%
Dec 31, 2013	91.22M	8.71M	10.55%
Dec 31, 2012	82.51M	4.56M	5.85%
Dec 31, 2011	77.95M	-11.69M	-13.04%
Dec 31, 2010	89.64M	-36.27M	-28.81%
Dec 31, 2009	125.91M	-14.23M	-10.16%
Dec 31, 2008	140.14M	-3.48M	-2.42%
Dec 31, 2007	143.62M	24.94M	21.02%
Dec 31, 2006	118.67M	20.11M	20.41%
Dec 31, 2005	98.56M	18.55M	23.19%
Dec 31, 2004	80.01M	14.33M	21.82%
Dec 31, 2003	65.68M	13.70M	26.35%
Dec 31, 2002	51.98M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.